TEHRAN -- Iranian researchers in a joint research with U.S. scholars has designed an artificial intelligence algorithm to detect cancerous tissues.
Sadegh Kazzemi Fard, the manager of the project named as the Sina artificial intelligence model, described the high accuracy of diagnosis as one of the advantages of the method.
“The artificial intelligence algorithm developed by identifying cancer tissue in the early stages enables doctors to prevent the spread of the disease,” he said.
“The Sina artificial intelligence model has been approved by the World Health Organization (WHO) and will be available to medical and research centers from the beginning of 2025,” he added.
“In its latest clinical trial, the Sina artificial intelligence algorithm once again demonstrated its ability to accurately diagnose cancer and was able to identify a cancerous mass in the breast tissue of a young woman, which was mistakenly diagnosed as a cyst in the initial tests,” Kazzemi Fard said.
“This patient, who was diagnosed with suspected cancer in routine examinations, was accurately identified with the help of artificial intelligence and mammography of the cancer tissue in two places, and the disease was confirmed with a biopsy, and the treatment process began for the patient,” he explained.
In May, a researcher at the Tarbiat Modares University (TMU) in Iran designed and produced electrochemical biosensors for the early detection of microRNAs that are involved in breast cancer.
According to the World Health Organization’s statistics, breast cancer and lung cancer are the most prevalent cancers among people worldwide, with the breast cancer being the most prevalent cancer among Iranian women.
Breast cancer can be seen in both women and men, but its prevalence is much higher in women than in men.